Log inRegister

COVID-19 INFORMATION

(updated: 02/07/2022)

On this page, you will find all of the current information we have regarding COVID-19.

Scroll down the page or click the button to jump to that section.

UHMS Position and Guidance
Research
Policies and Regulations
Position Statements & Guidelines – non UHMS
Social Media & External Programming

UHMS Position and Guidance

Hyperbaric Oxygen and COVID-19: Clinical trials registered on clinicaltrials.gov (updated: 8-12-2020)
Return to Diving Post COVID-19
Guidelines for infection control, patient treatment, and staff safety considerations related to Hyperbaric Oxygen Therapy (HBO2) in monoplace and multiplace hyperbaric chambers during the novel coronavirus disease (COVID-19) outbreak
Disinfecting hyperbaric chambers concerning COVID-19
Frequency of terminal clean for monoplace chambers concerning COVID-19
UHMS Position Statement: Hyperbaric Oxygen (HBO2) for COVID-19 Patients

Research

Physiologic and biochemical rationale for treating COVID-19 patients with hyperbaric oxygen.
UHM 2021, VOL. 48 NO. 1 – HYPERBARIC OXYGEN AND COVID-19
Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls.
UHM 2020, VOL. 47 NO. 3 – PRELIMINARY STUDY OF HYPERBARIC OXYGEN THERAPY FOR COVID-19
COVID-19-HBO Multicenter Trial Invitation
Synopsis: UHMS Hyperbaric Oxygen Therapy Committee Meeting on COVID-19 and HBO2
COVID-19 PHYSICIAN PRACTICE FINANCIAL IMPACT SURVEY RESULTS

Evidence Review for HBO2 Treatment of COVID-19 Webinar Video

Printed material including questions and answers from faculty
Presentation handouts
Abstracts
Abstracts handouts/posters
Hyperbaric oxygen as a treatment for COVID-19 infection?
UHM 2020, VOL. 47 NO. 2; Editorial Comentary: Richard Moon, MD and Lindell Weaver, MD
Hyperbaric oxygen therapy may be effective to improve hypoxemia in patients with severe COVID-2019 pneumonia: two case reports.
UHM 2020, VOL. 47 NO. 2., Dazhi Guo, Shuyi Pan, MaoMao Wang, Yufeng Guo
NBDHMT Credit Revision for Evidence Review for HBO2 treatment of COVID-19 Webinar

Policies and Regulations

CARES Act Provider Relief Fund:
If you ceased operation as a result of the COVID-19 pandemic, you are still eligible to receive funds so long as you provided diagnoses, testing, or care for individuals with possible or actual cases of COVID-19. Care does not have to be specific to treating COVID-19. HHS broadly views every patient as a possible case of COVID-19.
American Board of Preventive Medicine Implements a Policy of Accommodation for Residents and Fellows Affected by COVID-19 Outbreak

Position Statements & Guidelines – non UHMS

Hyperbaric Oxygen Therapy (HBOT) in the Emergency from COVID-19: Position Statement in Italy
Novel Coronavirus (COVID-19) Guidance for Diving Contractors
UC San Diego Guidelines for Evaluation of Divers during COVID-19 pandemic
ECHM position on HBO2 Therapy in multiplace hyperbaric chambers during COVID-19

Social Media & External Programming

How to Do the Right Thing Ethically Regarding HBOT for COVID-19 Pneumonia
ACHM: Webinar: COVID-19 & HBO: What We Know and What We Don't
AMA's role in COVID-19 pandemic
Undersea and Hyperbaric Medical Society
631 US Highway 1, Suite 307
North Palm Beach, FL 33408
Phone: 919.490.5140 | 877.533.8467
Fax: 919.490.5149
Email: uhms@uhms.org

General Information

Membership

Chapters

Corporate Partner

Annual Awards

Associates Of UHMS

Web Browsers We Support

Microsoft Edge, Google Chrome, Safari, Firefox, any Chromium-based browser.

Copyright © Undersea & Hyperbaric Medical Society | All rights reserved